A proof-of-concept study opens up an avenue for treating solid tumours that express low levels of a target antigen.

Pro-inflammatory M1 macrophages involved in immune responses accelerate the progression of melanoma through the extracellular ...

Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate ...

A new method can produce specially designed proteins that can arm T cells to attack cancer cells. Precision personalized cancer treatment on a larger scale has come a step closer after researchers ...

Please provide your email address to receive an email when new articles are posted on . AAnet characterized five different cell archetypes in triple-negative breast cancer, including those that have ...

A Phase 1 trial testing TG Therapeutics' CAR T-cell therapy azer-cel in progressive forms of MS is now recruiting across ...

An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators ...